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OBJECTIVES Using a model of arrhythmias associated with ischemic left ventricular (LV) dysfunction, this
study investigated autonomic and electrophysiologic mechanisms associated with sudden
cardiac death (SCD) in chronic heart failure (HF).
BACKGROUND Left ventricular dysfunction from ischemic heart disease is associated with many instances of
SCD. Electrophysiologic and autonomic derangements occur in HF, but their contribution
to SCD risk is poorly understood.
METHODS Sudden death risk was assessed in 15 dogs with a healed anterior myocardial infarction (MI)
during submaximal exercise and brief acute circumflex ischemia. Left ventricular dysfunction
was then induced by repetitive circumflex microembolization until LV ejection fraction
reached 35%. Before embolization, six dogs were susceptible to SCD, and nine were resistant.
RESULTS Baroreflex sensitivity was lower in susceptible dogs (10 ms/mm Hg 6 4 ms/mm Hg vs.
20 ms/mm Hg 6 11 ms/mm Hg, p 5 0.04). QT intervals from susceptible dogs were longer
after MI (246 ms 6 26 ms susceptible vs. 231 ms 6 20 ms resistant, p , 0.001) and
prolonged within eight weeks after LV dysfunction was established (from 246 ms 6 26 ms
to 274 ms 6 56 ms, 111%, p , 0.01). Heart rate in susceptible dogs increased during
transient ischemia (120%) and with progressive LV dysfunction (102 beats/min 6
28 beats/min baseline to 154 beats/min 6 7 beats/min LV dysfunction, p 5 0.003). All
susceptible dogs had spontaneous sustained ventricular tachycardia culminating in SCD. In
contrast, QT intervals in resistant dogs prolonged after 24 6 6 weeks (from 231 ms 6 20 ms
to 238 ms 6 15 ms, p , 0.05), and heart rates were unchanged. Only one resistant dog died
suddenly with LV dysfunction.
CONCLUSIONS Depressed vagal and elevated sympathetic control of heart rate coupled with abnormal
repolarization are associated with high SCD risk when post-MI LV dysfunction develops.
(J Am Coll Cardiol 2001;37:1741–8) © 2001 by the American College of Cardiology
Patients with chronic heart failure (HF), most commonly
the result of ischemic heart disease (1), are at risk for sudden
cardiac death (SCD) arising from malignant ventricular
tachyarrhythmias (2,3). A large body of evidence describes
left ventricular (LV) mechanical remodeling leading to
death from irreversible pump failure (4–6), but little is
known about electrical remodeling of the ischemic heart
with LV dysfunction leading to SCD in patients who
otherwise have few congestive symptoms (7). Recent trials
(8–10) document the efficacy of antiadrenergic therapy in
reducing SCD in patients with HF and demonstrate a
critical role of sympathetic activity in arrhythmogenesis in
the failing ventricle. However, specific mechanisms by
which antiadrenergic therapy reduces lethal arrhythmias are
not clear.
This limited understanding of SCD mechanisms is partly
due to a lack of appropriate animal models of HF suitable
for studying the arrhythmia process over time (11). The
most common large animal model of HF induces LV
dysfunction with high-rate pacing (11). Pacing-induced
mechanical dysfunction, however, spontaneously resolves
shortly after pacing is terminated (11), which makes it less
suitable for chronic evaluation. Furthermore, the very nature
of tachycardia-induced LV dysfunction directly relates to
nonischemic dilated cardiomyopathies, and extrapolation of
arrhythmia mechanisms from this model to ischemic HF
may be inappropriate. Finally, seldom is SCD predictable in
most large animal models of HF, which hinders accurate
conclusions about mechanisms that actually lead to lethal
arrhythmias. Canine models of chronic ischemic heart
disease and LV dysfunction have described important as-
pects of ventricular remodeling and nonlethal arrhythmo-
genesis (12–15), but several important questions about
life-threatening arrhythmias in chronic LV dysfunction
remain unanswered.
This report describes the characteristics of a new canine
model designed to address mechanisms of SCD during
moderate chronic LV dysfunction arising from ischemic
heart disease. Autonomic and repolarization abnormalities
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associated with spontaneous SCD were investigated in two
discrete groups of dogs with very different spontaneous
arrhythmia development during progression from myocar-
dial infarction (MI) to HF.
METHODS
Surgical preparation. The novel model of chronic isch-
emic HF reported here is partly based on an established
conscious dog model of post-MI SCD (16). Mongrel dogs
were instrumented with an anterior MI by ligation of the
left anterior descending artery during thoracotomy under
general anesthesia. A Doppler flow probe and vascular
occluder were placed around the circumflex, and a catheter
was placed in the descending aorta. Each animal received
immediate postoperative short-term analgesia (pentazocine
lactate, 1 mg/kg, intramuscularly) followed by a longer
acting analgesic (nalbuphine HCl, 0.5 mg/kg, intramuscu-
larly). Guidelines outlined by the National Institutes of
Health, American Physiological Society and the American
Heart Association pertaining to the appropriate care and use
of animals were strictly followed. Thirty days of recovery
and acclimation to the facilities and personnel were allowed
before any testing was started.
Baroreflex sensitivity (BRS). All animals were acclimated
to the testing environment and personnel. Baroreflex sen-
sitivity was measured according to published methods (17).
The slope of a regression line relating phenylephrine-
induced blood pressure rise to RR interval slowing defined
BRS, and only significant correlations (R . 85%) were
used. Baroreflex sensitivity testing was performed 30 days
after MI but before the exercise and ischemia test and before
the microembolization procedures.
Risk for ventricular fibrillation after MI with normal LV
function. To evaluate the post-MI risk for lethal arrhyth-
mias during transient ischemia 30 days after MI, each dog
exercised in a submaximal stress test protocol as previously
published (16). When target heart rate was reached (210 to
220 beats/min), the circumflex occluder was inflated for
2 min: the animals continued to run during the first minute
and exercise was stopped during the second minute. Dogs
developing ventricular fibrillation (VF) during the 2 min of
myocardial ischemia lost consciousness and then were defi-
brillated. These animals were labeled “susceptible” or “high-
risk” for VF. The remaining animals did not develop
sustained ventricular arrhythmias and were labeled “resis-
tant” or “low-risk” for VF. This protocol is associated with
a .90% reproducibility of risk status (18).
Microembolization to produce chronic LV dysfunction.
Ischemic LV dysfunction was produced by repeated micro-
embolization of the circumflex coronary artery using a
method previously described (12). Instrumented and char-
acterized post-MI dogs were sedated for each embolization
procedure with propafol (1 mg/kg, to effect, intravascularly).
The left or right femoral artery was isolated using sterile
technique over local anesthesia with lidocaine (2 to 3 cc, 1%
solution, SQ). A purse-string suture (4-O silk) was placed
in the artery wall, and a small arteriotomy was made with an
18-gauge needle. A 6.5F introducer sheath system (Daig
Corp., Minnetonka, Minnesota) was advanced into the
lumen of the artery over a wire. Using a 6.0F Judkins left 3.5
diagnostic coronary catheter (Medtronic, Inc., Danvers,
Missouri), the left main coronary artery was engaged under
fluoroscopic guidance. The left circumflex coronary artery
was identified and subselected using angiographic contrast.
Once the circumflex coronary artery was engaged, 1.5 to
3 cc of 90 m warmed and sonicated latex beads (2.53%
solids, Polysciences, Inc., Warrington, Pennsylvania) were
slowly injected and flushed into the artery. The catheter was
removed and the purse-string suture closed to ensure he-
mostasis. The wound was closed with 2-0 absorbable suture,
and skin staples were placed. The electrocardiogram (ECG)
was monitored during the procedure and for 30 min after
embolization. Dogs recovered in a special high-flow oxygen
cage and received postprocedure analgesia (nalbuphine
0.5 mg/kg, intramuscularly). The procedure was repeated
weekly until the target LV ejection fraction (LVEF) was
reached (LVEF approximately 35%).
LV function assessment. To monitor decline of LV func-
tion, modified two and four chamber two-dimensional
echocardiogram images of the heart were made from the
apex of the sternum along the long-axis of the LV using a
3.5 MHz transducer. Endocardial definition was maximized
and traced in both the two and four chamber views. Systolic
and diastolic LV volumes and calculated LVEF were
averaged from both orthogonal views. The mitral valve was
interrogated using color Doppler to identify the presence of
significant mitral regurgitation.
Arrhythmia monitoring and QT interval measurements.
Transthoracic modified lead I ECG was digitally acquired
at baseline and three times a week after the target ejection
fraction was reached and daily after arrhythmias appeared.
Electrocardiogram recordings were performed while the
animal was supine at rest during the midmorning time. The
ECGs were digitized, and QT intervals were measured from
QRS complexes at various cycle lengths and used to com-
pare resistant and susceptible dogs. Eight to ten QT
intervals were measured at matched RR intervals (65 ms)
after MI and periodically after LVEF reached 35 6 4%,
including the last recording before death. QT intervals were
consistently available in five resistant and five susceptible
Abbreviations and Acronyms
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dogs. In order to match the higher heart rate of susceptible
dogs with LV dysfunction, QT intervals in resistant dogs
were measured during increased heart rate in response to
routine activity in the laboratory. Additionally, QT interval
measurements were made in 10 normal dogs at different
heart rates obtained during routine recordings in the same
conditions used for the study groups. This was done to
generate normal distribution curves relating QT and RR
intervals. This design avoided potential confounding influ-
ences of heart rate correction algorithms and increased the
likelihood of reflecting real changes in QT measurements.
Pathological examination. Postmortem analysis was per-
formed in four susceptible and three resistant dogs to assess
infarct size and pathological consequences of the microem-
bolization. Resistant animals were euthanized by overdose
of sodium pentobarbitol, and the heart was immediately
excised and put in a 10% formalin solution. In susceptible
dogs, hearts were excised as soon as the dog was found dead.
Hearts were cut into five to six slices, 1 cm thick, were
photographed, and the images were digitized. The total
areas of the LV and the infarct zone were calculated using
computerized software (Autodesk AutoCAD R14.0,
Manchester, UK). Wall thickness was also measured.
Serum catecholamines. Serum catecholamine analysis was
performed by the hospital laboratory service at the Univer-
sity Hospital of the University of Oklahoma Health Sci-
ences Center. Whole blood was centrifuged, and serum was
eluted. The serum was immediately processed to measure
total catecholamines, norepinephrine, epinephrine and do-
pamine. Blood was obtained after two weeks of reaching the
target LVEF.
Statistical analyses. Differences in QT intervals and heart
rates in the same animals under different conditions
(post-MI and HF ) were compared with analysis of variance
(ANOVA) for repeated measures. Differences between
groups for these parameters were evaluated with ANOVA.
Other comparisons, such as ejection fraction, ventricular
volumes, size of MI, BRS and catecholamines were evalu-
ated with a Student t test for group comparison. Frequency
of SCD within the two groups was analyzed using the
Fisher exact test. To describe the normal QT and RR
interval relationship, nonlinear regression analysis was used
to generate the best-fit line illustrating the relationship in
normal dogs only. An alpha level of p , 0.05 was consid-
ered significant. Data are presented as mean 6 SD unless
otherwise noted.
RESULTS
Risk for post-MI ventricular fibrillation with normal LV
function. Fifteen dogs underwent the exercise and myocar-
dial ischemia test 30 days after MI. Six dogs developed VF
and were successfully defibrillated (susceptible). Nine dogs
had no sustained ventricular arrhythmias (resistant) during
acute myocardial ischemia.
Susceptible dogs had a sustained tachycardia in response
to acute myocardial ischemia with heart rates averaging 212
beats/min 6 15 beats/min at the onset of coronary occlusion
and accelerating to 255 beats/min 6 16 beats/min (p ,
0.001) after 30 s of coronary occlusion or just before VF if
it occurred before 30 s. Resistant dogs were characterized by
a lack of cardioacceleration during acute ischemia with heart
rates averaging 203 beats/min 6 28 beats/min at the onset
of coronary occlusion and 200 beats/min 6 29 beats/min
after 30 s of myocardial ischemia (p 5 0.1). No resistant dog
had ventricular ectopy during myocardial ischemia. These
findings are consistent with previously published character-
istics of the model (16,19–21).
BRS. Baroreflex sensitivity after MI, but before microem-
bolization, was lower in susceptible dogs compared with the
resistant group. Baroreflex sensitivity in susceptible dogs
averaged 10 ms/mm Hg 6 7 ms/mm Hg compared with
20 ms/mm Hg 6 11 ms/mm Hg in resistant dogs (p 5
0.04).
Microembolization to produce LV dysfunction. Emboli-
zation of the circumflex coronary artery successfully im-
paired LV function in the resistant (LVEF from 62 6 4%
to 35 6 3%) and the susceptible (LVEF from 66 6 3% to
35 6 4%) dogs. Left ventricular end diastolic volume was
not changed by the time the susceptible dogs died suddenly
(45 cc 6 16 cc to 46 cc 6 15 cc, p . 0.1). In fact, by the
time susceptible dogs developed SCD, there was no signif-
icant ventricular dilation in either group. However, after six
to eight months of follow-up, the ventricles in resistant
dogs eventually dilated from an LV end diastolic volume
of 43 cc 6 20 cc to 60 cc 6 21 cc (p , 0.001). Left
ventricular ejection fraction remained 35 6 3% in resistant
dogs throughout the follow-up period despite progressive
dilation. No animal developed severe mitral regurgitation,
and there were no differences in the amount (trace to mild)
of mitral regurgitation between the two groups of dogs. No
animal developed ascites, rales or any finding consistent
with New York Heart Association class IV HF.
Incidence of spontaneous arrhythmias. Incidence of
SCD was significantly higher in susceptible dogs (p 5
0.001). This group developed premature ventricular con-
tractions (PVCs) within days of reaching an LVEF of 35%
and progressed rapidly to nonsustained then sustained
ventricular tachycardia (Fig. 1 and 2). By eight weeks, all
susceptible dogs died suddenly after having sustained or
nonsustained ventricular tachycardia before their death. All
animals were noted to be alive at the end of the day and were
found dead in their cage the next morning.
Resistant dogs developed only PVCs over a much longer
period of time (24 weeks 6 6 weeks of observation, Fig.
1B), and only one dog died suddenly three weeks after
reaching the target LVEF. No sustained arrhythmias were
documented in the resistant dogs after production of LV
dysfunction.
Repolarization abnormalities, heart rate and SCD during
progressive LV dysfunction. Arrhythmia progression in
susceptible dogs was associated with a persistent sinus
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tachycardia from 102 beats/min 6 28 beats/min at baseline
to 144 beats/min 6 8 beats/min when LVEF was 35% and
154 beats/min 6 7 beats/min immediately before SCD
(p , 0.01). Resistant dogs did not have a change in heart
rate throughout the six month follow-up (96 beats/min 6 7
beats/min at baseline, 106 beats/min 6 19 beats/min at an
LVEF of 35%, 101 beats/min 6 23 beats/min at six months
after an LVEF of 35%, p 5 0.1). After induction of LV
dysfunction, five susceptible and five resistant dogs had a
strikingly different QT interval evolution. QT interval
analyses were performed using absolute QT values at com-
parable RR intervals to avoid the risk of overcorrection that
may occur when using the Bazett formula at high heart
rates.
The opposite pattern of arrhythmia progression between
the two groups might have been, in part, predicted by
examination of QT values after MI and before the occur-
rence of LV dysfunction. QT intervals were longer in
susceptible dogs (246 ms 6 26 ms susceptible vs. 231 ms 6
20 ms resistant, p , 0.01) one month after MI with normal
LV function. Three weeks after LVEF 35% was obtained,
the QT interval of resistant dogs became slightly prolonged
from 231 ms 6 20 ms to 238 ms 6 13 ms (p 5 0.03, Fig.
3). By six months, the resistant dogs’ QT interval was
247 ms 6 20 ms (p , 0.05 vs. post-MI). In contrast, the
QT interval lengthened in susceptible dogs from 246 ms 6
26 ms to 274 ms 6 56 ms within three weeks of ischemic
LV dysfunction (p , 0.01, Fig. 3).
Pathological findings. The size of the MI from the left
anterior descending coronary artery ligation was not differ-
ent in the two groups (5 6 2% vs. 4 6 2%, p 5 NS).
Fibrotic tissue in the embolized LV posterior-lateral wall
was similarly distributed in high- and low-risk dog hearts.
However, susceptible dogs tended to have more hypertro-
phy in the anterior wall (1.2 cm 6 0.3 cm susceptible vs.
0.9 cm 6 0.2 cm resistant, p 5 0.10) and posterior wall
(1.3 mm 6 0.2 mm susceptible vs. 0.9 mm 6 0.2 mm, p 5
0.08).
Serum catecholamines. Serum catecholamines were
available in four susceptible and four resistant animals.
Total catecholamines were higher in susceptible dogs
(1,017 ng/dl 6 323 ng/dl vs. 661 ng/dl 6 191 ng/dl,
p , 0.05) accounted for by increased norepinephrine in
susceptible dogs (715 ng/dl 6 276 ng/dl vs. 463 ng/dl 6
183 ng/dl, p , 0.05). Epinephrine and dopamine were not
different between the groups.
DISCUSSION
This work reports two characteristics that promise to shed
light on the mechanisms of SCD in ischemic HF. First,
dogs with autonomic imbalances favoring the sympathetic
nervous system after MI, but before LV dysfunction, rapidly
developed lethal arrhythmias as ischemic heart disease
progressed. Since the high-risk animals had very little
“congestive” symptoms, we describe their progression as
“arrhythmogenic HF.” Second, dogs that died suddenly lost
the ability to adapt ventricular repolarization to shortening
cycle length. Left ventricular dysfunction did not differ
between the two groups of animals, so the observed alter-
ation in repolarization adaptation may represent a primary
electrical remodeling specifically occurring in susceptible
animals but not in resistant dogs. These findings suggest a
link between pathologic autonomic control of heart rate and
abnormalities of repolarization leading to SCD early in the
progression of ischemic heart disease into HF.
Novel animal model of ischemic HF. The model de-
scribed in this study is new and combines a chronic infarct
matrix with ongoing small vessel coronary disease to pro-
duce moderate levels of LV dysfunction. Stable LV dys-
function typical of this preparation allowed time to analyze
repolarization abnormalities and unambiguously associate
Figure 1. Incidence of spontaneous ventricular arrhythmias in susceptible
(A) and resistant (B) dogs as ischemic heart failure progressed over time
(p 5 0.001 susceptible vs. resistant SCD). Baseline arrhythmia incidence
was when the left ventricular ejection fraction reached the target range
(35%, see text). 0 5 no arrhythmias; PVC 5 premature ventricular
contraction; SCD 5 sudden cardiac death; VTns 5 nonsustained ventric-
ular tachycardia (,20 beats); VTs 5 sustained ventricular tachycardia
(.20 beats).
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them with lethal arrhythmia development. This animal
model is partially based on the experimental preparation of
SCD after MI (normal LV function) developed by
Schwartz, Billman and Stone (16). Several general princi-
ples of arrhythmia mechanisms after a first MI were
described in that model (16,19–22) and were subsequently
clinically validated (23,24).
Considering the etiology of LV, dysfunction in an exper-
imental HF model is important since the clinical character-
istics of arrhythmias in ischemic heart disease may be
different from those of nonischemic origin. Ischemic HF
has regional abnormalities of mechanical and electrical
function adjacent to normal or hypertrophied myocardium.
This heterogeneous substrate contrasts with nonischemic
cardiomyopathies, which generally have global homoge-
neous dysfunction (11). An important and widely used
model of HF, pacing induced cardiomyopathy, accurately
duplicates a homogeneous dilated cardiomyopathic process,
and findings from that model are applicable to human
disease (11). However, what is lacking in the literature is a
large animal HF model that duplicates the heterogeneity of
ischemic HF accompanied with predictable risk for lethal
arrhythmias. The model presented in this study was de-
signed to address this gap in understanding and demon-
strated very distinct differences in arrhythmia characteristics
and risk based on individual autonomic control of heart rate
and repolarization kinetics.
Autonomic mechanisms of arrhythmogenic HF. Auto-
nomic mechanisms found in this study challenge the tradi-
tional paradigm that sympathetic activation arises only from
reflex adaptation to a loss of cardiac output in HF. The
traditional neurohumoral view of HF explains why there is
a relationship between circulating catecholamines, func-
tional class and total mortality (25,26). Unfortunately, after
Figure 2. An example of spontaneous arrhythmia progression over time in a susceptible (A) and resistant (B) dog with ischemic heart disease and moderate
left ventricular dysfunction (EF approximately 35%). Note the rapid progression to sustained, incessant ventricular tachycardia in the susceptible dog within
three months. In contrast, the resistant dog had isolated premature ventricular contractions after six months of follow-up. Left ventricular ejection fractions
in the two dogs were similar. EF 5 ejection fraction; MI 5 myocardial infarction.
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20 years of understanding HF as a neurohumoral disease
process, there are still few clues to explain why patients with
similar LV dysfunction may or may not have autonomic
derangements and, more importantly, may or may not die of
arrhythmic death.
This study further supports the hypothesis that cardio-
cardiac reflexes (27) originating from the damaged ventricle
initiate adverse sympathetic activation coupled with vagal
withdrawal (28) independent from hemodynamic effects. In
this study, a clear association between abnormal cardiac
autonomic control in susceptible subjects and a rapid pro-
gression of electrophysiological alterations was found. Al-
though cause and effect cannot be established, these findings
suggest that abnormal autonomic control of the heart may
be linked to electrophysiologic derangements leading to
SCD in ischemic LV dysfunction.
Clinical application of these results must be done care-
fully and tempered by the limitations of animal models in
general. For example, epicardial vessel ligation and micro-
embolization are intended to duplicate chronic, combined
with subacute, large and small vessel coronary artery disease.
This process does not exactly duplicate the chronic process
of atherosclerotic coronary disease, nor does it approximate
the length of human disease. Even with these limitations,
however, the results suggest that there may be two groups of
patients that develop ischemic LV dysfunction differenti-
ated by their risk for SCD. Patients who exhibit “arrhyth-
mogenic HF” may not survive LV dysfunction long enough
to be involved in clinical trials. If this were true, traditional
approaches to risk stratification would be applied to the
survivors, who are, by definition, at relatively low-risk for
SCD. In fact, the lack of accurate risk stratification by
traditional means has led to large clinical trials examining
the hypothesis that all patients with LV dysfunction should
receive an implantable defibrillator (29). Hopefully, a better
understanding about the target populations coupled with
elaboration of autonomic and electrophysiologic mecha-
nisms of arrhythmias in ischemic HF will lead to better risk
assessment.
Abnormalities of repolarization. Normally, ventricular re-
polarization shortens when the heart rate increases. This
important characteristic of the ventricle reduces the chance
of excessively long QT intervals at short cycle lengths with
the attendant risk for life-threatening arrhythmias. In this
study, susceptible dogs quickly developed abnormal QT
interval prolongation with shorter cycle lengths, which may
reflect a defect in ion channels responsible for ventricular
repolarization found in this group. Depressed expression
of repolarizing currents occurs in ventricular myocytes
both from experimental HF preparations and from human
Figure 3. Representative examples of QT intervals at different cycle lengths from one susceptible (A) and one resistant (B) dog 30 days after myocardial
infarction (open circles) and after development of ischemic left ventricular dysfunction (open triangles). The normal QT and RR interval relationship is
demonstrated from 10 normal dogs in the closed circles. Nonlinear regression analysis was used to produce the best-fit line to illustrate the normal QT
to RR interval relationship. EF 5 ejection fraction; MI 5 myocardial infarction.
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hearts with cardiomyopathy. Specifically, the transient out-
ward potassium channel, Ito, is underexpressed in cardio-
myopathic human hearts and pacing induced animal HF,
leading to prolongation of cellular action potential (30,31).
Additionally, Iks current is reduced in LV hypertrophy
induced by chronic atrioventricular block (32). More recent
studies demonstrate abnormalities in cellular calcium kinet-
ics, which are also important mechanisms in action potential
prolongation of HF (33).
Additionally, tissue heterogeneity in the current model,
which duplicates clinical reality, probably produced regional
abnormalities of ion channels responsible for repolarization.
This type of heterogeneity alters action potential duration
rate dependence (34) and may critically increase dispersion
of repolarization, thus setting the stage for lethal arrhyth-
mias.
Conclusions. This study describes a new chronic animal
model of ischemic LV dysfunction in which dogs at high-
risk for spontaneous SCD can be reliably identified. The
main findings are that autonomic imbalances, present before
HF develops in subjects with ischemic heart disease, are
associated with lethal arrhythmias as LV dysfunction
progresses. QT interval prolongation and the loss of repo-
larization adaptation to short cycle lengths complete the
high-risk matrix. Overall this model provides novel infor-
mation to understand SCD in HF and sets the stage for
further studies aimed at describing neural and cellular
mechanisms of arrhythmogenic HF.
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